Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

DVA
DaVita Inc.
stock NYSE

At Close
Aug 14, 2026 3:59:49 PM EDT
180.15USD+0.547%(+0.98)506,453
171.76Bid   180.54Ask   8.78Spread
Pre-market
Aug 10, 2026 9:27:30 AM EDT
183.50USD+2.417%(+4.33)0
After-hours
Aug 13, 2026 4:10:30 PM EDT
179.17USD+0.017%(+0.03)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 27, 2022
04:06PM EST  DaVita Inc. Schedules 4th Quarter 2021 Investor Conference Call   PR Newswire
Jan 19, 2022
06:02AM EST  Kidney Doctors, Transplant Providers Work with DaVita in New Government Program   PR Newswire
Jan 18, 2022
06:09AM EST  DaVita Announces Acquisition Of MedSleuth   RTTNews
06:04AM EST  DaVita Acquires MedSleuth; Terms Not Disclosed   Benzinga
06:02AM EST  DaVita Acquires MedSleuth, Deepens Efforts to Improve Transplant Experience   PR Newswire
Jan 12, 2022
06:02AM EST  DaVita Teammates Transformed Care for Thousands of Patients in 2021   PR Newswire
Jan 6, 2022
06:02AM EST  DaVita Celebrates 10 Years of Kidney Smart(r) Educational Programming   PR Newswire
Jan 5, 2022
09:39AM EST  Truist Securities Maintains Hold on DaVita, Raises Price Target to $125   Benzinga
Dec 16, 2021
06:06AM EST  DaVita Integrated Kidney Care Names David Roer Chief Medical Officer   RTTNews
06:02AM EST  DaVita Integrated Kidney Care Expands Clinical Leadership Team   PR Newswire
Dec 9, 2021
06:04AM EST  DaVita Says Its North American Operations Powered By 100% Renewable Energy   RTTNews
06:02AM EST  DaVita's North American Operations Now Powered by 100% Renewable Energy   PR Newswire
Nov 30, 2021
06:02AM EST  15th Annual Tour DaVita Raises Nearly $1 Million for Bridge of Life   PR Newswire
Nov 29, 2021
06:06AM EST  DaVita Clinical Research Study Indicates Effectiveness Of mRNA COVID-19 Vaccines In Dialysis Patients   Benzinga
06:01AM EST  DaVita Clinical Research Study Indicates Effectiveness of mRNA COVID-19   PR Newswire
Nov 4, 2021
06:04AM EDT  DaVita Clinical Research to Present New Findings at American Society of   PR Newswire
Nov 1, 2021
06:02AM EDT  The American Diabetes Association(r) and DaVita Raise Awareness about the Link   PR Newswire
Oct 29, 2021
09:26AM EDT  RBC Capital Maintains Sector Perform on DaVita, Lowers Price Target to $111   Benzinga
Oct 28, 2021
04:13PM EDT  DaVita Q3 EPS $2.36 Vs. $1.28 Year Ago   RTTNews
04:13PM EDT  DaVita HealthCare Partners Inc. (DVA) released earnings for its third quarter that advanced from last year.   RTTNews
04:09PM EDT  DaVita Sees FY21 Adj. Operating Income $1.76B-$1.81B   Benzinga
04:07PM EDT  DaVita Q3 EPS $2.36 Beats $2.25 Estimate, Sales $2.94B Beat $2.93B Estimate   Benzinga
04:06PM EDT  DaVita Inc. 3rd Quarter 2021 Results   PR Newswire
04:08AM EDT  Earnings Scheduled For October 28, 2021   Benzinga
Oct 21, 2021
07:00AM EDT  Renalytix plc (NASDAQ: RNLX),(LSE: RENX) an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care,announces its results for the twelve months ended 30 June 2021.   GlobeNewswire Inc
Oct 19, 2021
06:01AM EDT  DaVita Inc. Schedules Virtual Capital Markets Day for November 16, 2021   PR Newswire
06:01AM EDT  DaVita Inc. Schedules 3rd Quarter 2021 Investor Conference Call   PR Newswire
Oct 13, 2021
01:38PM EDT  Truist Securities Maintains Hold on DaVita, Lowers Price Target to $125   Benzinga
Oct 11, 2021
06:14AM EDT  DaVita announced commitment to climate action goals with validation from the Science Based Targets initiative (SBTi). The organization has approved two goals supply chain partners representing 70% of emissions will set climate change goals by 202; reduce its carbon emissions by 50% by 2025.   RTTNews
06:03AM EDT  DaVita Climate Action Goals Approved By Science Based Target Initiative   RTTNews
06:02AM EDT  DaVita Climate Action Goals Approved by the Science Based Target Initiative   PR Newswire
Sep 16, 2021
06:03AM EDT  DaVita Kidney Care Names Tina Livaudais New Chief Nursing Officer   RTTNews
06:02AM EDT  DaVita Kidney Care Names New Chief Nursing Officer   PR Newswire
Sep 10, 2021
10:06AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021   Benzinga
06:12AM EDT  A Peek Into The Markets: US Stock Futures Up Ahead Of Producer Price Index; Crude Oil Rises   Benzinga
05:13AM EDT  Cowen & Co. Initiates Coverage On DaVita with Market Perform Rating, Announces Price Target of $145   Benzinga
Sep 9, 2021
04:03PM EDT  DaVita Appoints Gregory Moore To Its Board Of Directors   RTTNews
04:02PM EDT  DaVita Announces Dr. Gregory Moore to Join its Board of Directors   PR Newswire
08:00AM EDT  Miromatrix Welcomes Dr. John Barry as Vice President of Research   GlobeNewswire Inc
Aug 20, 2021
11:00AM EDT  Looking into DaVita's Return on Capital Employed   Benzinga
Aug 12, 2021
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2021   Benzinga
06:21AM EDT  Barclays Downgrades DaVita to Equal-Weight, Raises Price Target to $146   Benzinga
Aug 11, 2021
07:38AM EDT  Miromatrix Medical Reports Strategic Investors Were Involved In Series C Financing Following IPO: Baxter, CareDx, DaVita; No Size Of Investment Disclosed   Benzinga
07:00AM EDT  Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients' lives and improve quality of life around the world, announced strategic investors involved in its Series C financing, which was followed by its June 24th IPO.   GlobeNewswire Inc
Aug 3, 2021
05:38PM EDT  DaVita: Q2 Earnings Insights   Benzinga
04:21PM EDT  DaVita HealthCare Partners Inc. (DVA) released earnings for its second quarter that climbed from last year.   RTTNews
04:13PM EDT  DaVita Raises FY21 EPS Guidance From $8.20-$9.00 To $8.80-$9.40 Vs. $8.57 Est.   Benzinga
04:12PM EDT  DaVita Q2 EPS $2.64 Beats $2.18 Estimate, Sales $2.92B Beat $2.87B Estimate   Benzinga
04:08PM EDT  DaVita Q2 EPS $2.64 Vs. $1.62 Year Ago   RTTNews
04:06PM EDT  DaVita Inc. 2nd Quarter 2021 Results   PR Newswire
03:52AM EDT  Earnings Scheduled For August 3, 2021   Benzinga
Jul 30, 2021
06:44AM EDT  DaVita's Debt Insights   Benzinga
Jul 21, 2021
04:00AM EDT  DaVita Inc. Schedules 2nd Quarter 2021 Investor Conference Call   PR Newswire
Jul 19, 2021
09:51AM EDT  Deutsche Bank Maintains Buy on DaVita, Raises Price Target to $207   Benzinga
09:39AM EDT  DaVita Shares Positive For Session; Hearing Deutsche Bank Sets Street High Price Target, Raises From $150 To $207   Benzinga
Jul 15, 2021
03:50PM EDT  U.S. Justice Department Says DaVita, Former CEO Indicted In Ongoing Investigation Of Labor Market Collusion In Health Care Industry   Benzinga
Jun 10, 2021
08:07AM EDT  DaVita And The National Kidney Foundation Collaborate To Improve Health Equity In Kidney Transplantation   RTTNews
08:04AM EDT  DaVita and the National Kidney Foundation Join Forces to Improve Health Equity   PR Newswire
Jun 2, 2021
06:09AM EDT  DaVita Kidney Care Launches Virtual Support Groups Through DaVita Care Connect For Home Dialysis Patients   RTTNews
06:07AM EDT  Virtual Support Groups Create Community for DaVita Home Dialysis Patients   PR Newswire
May 13, 2021
06:02AM EDT  Extraordinary Nurses at DaVita Kidney Care Honored with DAISY Awards   PR Newswire
May 10, 2021
11:26AM EDT  Stocks That Hit 52-Week Highs On Monday   Benzinga
06:02AM EDT  DaVita Kidney Care Announces Expansion Of Its Home Kidney Care Program   RTTNews
06:01AM EDT  DaVita to Further Elevate its Home Dialysis Care Experience with New Baxter   PR Newswire
Apr 29, 2021
05:55PM EDT  Thursday, dialysis service provider DaVita Inc. (DVA) on Thursday posted first-quarter net income of $237.4 million, lower than $240 million in the same period last year. On a per share basis, earnings rose to $2.09 from $1.89 a year ago.   RTTNews
04:51PM EDT  Recap: DaVita Q1 Earnings   Benzinga
04:51PM EDT  DaVita Sees FY 2021 Adj. Operating Income $1.75B-$1.875B   Benzinga
04:37PM EDT  DaVita Q1 EPS $2.09 Beats $1.80 Estimate, Sales $2.82B Inline   Benzinga
04:11PM EDT  DaVita Q1 EPS From Cont Ops $2.09, Up 15.5% From Last Year   RTTNews
04:06PM EDT  DaVita Inc. 1st Quarter 2021 Results   PR Newswire
04:10AM EDT  Earnings Scheduled For April 29, 2021   Benzinga
Apr 27, 2021
06:02AM EDT  DaVita Solidifies Commitment to ESG, Sets 2025 Goals   PR Newswire
Apr 22, 2021
04:06PM EDT  DaVita Inc. Schedules 1st Quarter 2021 Investor Conference Call   PR Newswire
Apr 12, 2021
10:01AM EDT  DaVita Says Blue Cross And Blue Shield Of Minnesota Launches Program With Co's VillageHealth To Improve Care For Members With Kidney Disease   Benzinga
10:01AM EDT  Blue Cross and Blue Shield of Minnesota Launches Program with DaVita's   PR Newswire
Mar 29, 2021
06:05AM EDT  DaVita Shares Strategy for Achieving a Diverse Community Where Everyone Belongs   PR Newswire
Mar 26, 2021
02:06PM EDT  BofA Downgrades DaVita On Low Exposure to Volume Rebound   Benzinga
10:23AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 26, 2021   Benzinga
08:38AM EDT  B of A Securities Downgrades DaVita to Underperform, Lowers Price Target to $118   Benzinga
Mar 25, 2021
11:02AM EDT  DaVita Issues Statement On Government's Nationwide Program To Vaccinate Dialysis Patients (Full Statement)   Benzinga
11:01AM EDT  DaVita Statement on Government's Nationwide Program to Vaccinate Dialysis   PR Newswire
Mar 23, 2021
08:03AM EDT  DaVita Kidney Care Expands Use Of NxStage Home Hemodialysis Machines From Fresenius Medical Care   RTTNews
08:01AM EDT  DaVita Kidney Care Expands Use of NxStage Home Hemodialysis Machines from   PR Newswire
Mar 9, 2021
03:00AM EST  DaVita Inc. to Participate in the 2021 Barclays Global Healthcare Conference   PR Newswire
Mar 2, 2021
07:00AM EST  Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (RenalytixAI or the Company), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the quarter and six months ended December 31, 2020.   GlobeNewswire Inc
Feb 24, 2021
06:01PM EST  DaVita Inc. Announces Upsize and Pricing of Add-On Offering of $1 Billion   PR Newswire
07:48AM EST  DaVita Announces Add-On Offering Of $750 Mln Senior Notes   RTTNews
07:45AM EST  DaVita Inc. Announces Add-On Offering of $750 Million Senior Notes   PR Newswire
Feb 16, 2021
01:56PM EST  DaVita Shares Spike Higher; Warren E. Buffett Reports A 33% Stake In Co   Benzinga
Feb 11, 2021
04:47PM EST  Recap: DaVita Q4 Earnings   Benzinga
04:39PM EST  DaVita HealthCare Partners Inc. (DVA) revealed earnings for fourth quarter that fell from the same period last year.   RTTNews
04:09PM EST  DaVita Q4 EPS From Cont Ops $1.67 Vs $1.86 Last Year   RTTNews
04:08PM EST  DaVita Sees FY21 Adj. EPS $7.75-$8.75 vs $8.16 Est.   Benzinga
04:07PM EST  DaVita Q4 EPS $1.67 Misses $1.87 Estimate, Sales $2.90B Miss $2.93B Estimate   Benzinga
04:06PM EST  DaVita Inc. 4th Quarter 2020 Results   PR Newswire
03:51AM EST  Earnings Scheduled For February 11, 2021   Benzinga
Feb 10, 2021
10:36AM EST  DaVita's Earnings Outlook   Benzinga
Feb 6, 2021
08:53PM EST  DVA Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Davita Inc   PR Newswire
Jan 29, 2021
05:49AM EST  DaVita Inc. Schedules 4th Quarter 2020 Investor Conference Call   PR Newswire
Jan 6, 2021
07:31AM EST  The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping   Benzinga
Jan 5, 2021
10:44AM EST  DaVita shares were trading lower after Bank of America downgraded the stock from Buy to Neutral and announced a price target of $127 per share.   Benzinga
10:11AM EST  Benzinga's Top Upgrades, Downgrades For January 5, 2021   Benzinga
09:59AM EST  A Look Into DaVita's Price Over Earnings   Benzinga
08:00AM EST  B of A Securities Downgrades DaVita to Neutral, Announces $127 Price Target   Benzinga
06:00AM EST  Early Risk Identification at Core of Innovative Kidney Care   GlobeNewswire Inc
Dec 22, 2020
10:38AM EST  P/E Ratio Insights for DaVita   Benzinga
06:11AM EST  DaVita Kidney Care Announces That More Than 100,000 DaVita Patients Have Received A Kidney Transplant Since 2000   RTTNews
06:07AM EST  DaVita Celebrates 100,000 Patients Receiving Kidney Transplants   PR Newswire
Nov 23, 2020
06:04AM EST  14th Annual Tour DaVita Raises Nearly $1 Million for Bridge of Life   PR Newswire
Nov 17, 2020
12:00PM EST  Q3 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios   Benzinga
Nov 5, 2020
09:52AM EST  68 Stocks Trading Near 52-Week Highs Just After Open On Thursday, Nov. 5, 2020:   Benzinga
Nov 4, 2020
10:09AM EST  Stocks Trading Near 52-Week Highs Just After Open On Wednesday, Nov. 4, 2020 Include NICE, ETN, CDNS, CARR, HUM, ANTM, Others   Benzinga
02:30AM EST  DaVita Kidney Care Says Grateful That Californians Voted Down Proposition 23   RTTNews
02:14AM EST  DaVita Responds to Proposition 23 in California   PR Newswire
Oct 29, 2020
04:10PM EDT  DaVita Raises FY20 Adj. EPS Guidance From $6.25-$6.75 To $7.35-$7.60 vs $6.85 Est., Narrows FY20 Sales Guidance From $11.5B-$11.7B To $11.5B-$11.6B vs $11.6B Est.   Benzinga
04:07PM EDT  DaVita HealthCare Partners Inc. (DVA) revealed a profit for its third quarter that climbed from the same period last year.   RTTNews
04:03PM EDT  DaVita Q3 Adj. EPS $1.80 Beats $1.44 Estimate, Sales $2.92B Miss $2.94B Estimate   Benzinga
04:03PM EDT  DaVita Q3 EPS $1.28 Vs. $0.95 Year Ago   RTTNews
04:01PM EDT  DaVita Inc. 3rd Quarter 2020 Results   PR Newswire
01:31PM EDT  Notable Earnings Watchlist For Thursday, Oct. 29, 2020 After Market Close: AAPL, MGM, X, PFPT, SHAK, ATVI, AMZN, MSI, MHK, TWTR, VRTX, WW, TEAM, SYK, SBUX, EMN, CHE, COLM, CENX, DECK, CAR, ATUS, ADM, AUY, DVA, GOOG, FTNT, FB   Benzinga
04:08AM EDT  Earnings Scheduled For October 29, 2020   Benzinga
Oct 28, 2020
10:04AM EDT  Earnings Outlook For DaVita   Benzinga
Oct 22, 2020
09:04AM EDT  DaVita Clinical Research to Present New Findings at American Society of   PR Newswire
09:02AM EDT  DavIta Clinical Research To Present New Findings At American Society Of Nephrology Kidney Week 2020   Benzinga
Oct 15, 2020
04:53PM EDT  DaVita Inc. Schedules 3rd Quarter 2020 Investor Conference Call   PR Newswire
Sep 27, 2020
06:12PM EDT  Notable Insider Buys Last Week: Snowflake, Broadcom And More   Benzinga
Sep 17, 2020
06:04AM EDT  DaVita Reports Final Results Of Self-Tender Offer   RTTNews
06:00AM EDT  DaVita Announces Final Results Of Self-Tender Offer   PR Newswire
Sep 15, 2020
06:43AM EDT  DaVita Announces Preliminary Results Of Self-Tender Offer For $1.0 Bln Common Stock   RTTNews
06:30AM EDT  DaVita Announces Preliminary Results of Self-Tender Offer   PR Newswire
Sep 8, 2020
06:02AM EDT  DaVita Announces Shawn Guertin To Join Board, Effective Sept. 15   RTTNews
06:01AM EDT  DaVita Announces Shawn Guertin Will Join its Board of Directors   PR Newswire
Aug 31, 2020
02:42PM EDT  A Look At Berkshire Hathaway's Top 9 Holdings On Warren Buffett's 90th Birthday   Benzinga
Aug 27, 2020
04:07PM EDT  DaVita Opens Its Doors to Hurricane Laura Evacuees Needing Dialysis   PR Newswire
Aug 20, 2020
06:30AM EDT  DaVita Clinical Research To Conduct COVID-19 Studies In   RTTNews
06:14AM EDT  DaVita Clinical Research Begins Enrollment On Clinical Research Trials To Study How COVID-19 Affects Dialysis Patients   RTTNews
06:12AM EDT  DaVita Clinical Research Begins Enrollment In Trial Studying Study COVID-19 Impact On Dialysis Patients   Benzinga
06:07AM EDT  Clinical Research Trials Underway to Study COVID-19 Impact on Dialysis Patients   PR Newswire
Aug 17, 2020
05:11AM EDT  DaVita Inc. (DVA) has commenced a modified "Dutch auction" tender offer for shares of its common stock for an aggregate purchase price of up to $1.0 billion at a price per share of not less than $77.00 and not more than $88.00. The tender offer will expire on September 14, 2020.   RTTNews
04:14AM EDT  DaVita Commences Modified "Dutch Auction" Tender Offer For Shares For Purchase Price Of Up To $1.0 Bln   RTTNews
04:00AM EDT  DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common   PR Newswire
Aug 13, 2020
04:08PM EDT  Myriad Genetics Appoints Paul J. Diaz as President and Chief   GlobeNewswire Inc
06:21AM EDT  DaVita Expands Tuition And Support Program For Clinical Teammates To Advance Nursing Education   RTTNews
06:17AM EDT  DaVita Expands Initiative to Advance Nursing Education   PR Newswire
Aug 11, 2020
04:42AM EDT  DaVita Appoints Paula Price To Board, Effective Sept 1   RTTNews
04:31AM EDT  DaVita Announces Paula A. Price to Join its Board of Directors   PR Newswire
Aug 6, 2020
06:03PM EDT  DaVita Reports Pricing Of $1.5 Bln Senior Notes Offering   RTTNews
06:02PM EDT  DaVita Inc. Announces Pricing of $1.5 Billion Senior Notes Offering   PR Newswire
07:28AM EDT  DaVita Inc. Begins Private Offering Of $1.5 Bln Of Senior Notes Due 2031   RTTNews
07:28AM EDT  DaVita Inc. Announces Offering of $1.5 Billion Senior Notes   PR Newswire
Jul 30, 2020
05:33PM EDT  DaVita HealthCare Partners Inc. (DVA) announced a profit for its second quarter that climbed from last year.   RTTNews
05:20PM EDT  DaVita (DVA) said, for fiscal 2020, the company's current outlook for adjusted net income per share from continuing operations is $6.25 to $6.75, compared to prior guidance range of $5.75 to $6.25. Revenue is anticipated in a range of $11.50 billion to $11.70 billion.   RTTNews
04:04PM EDT  DaVita Q2 EPS $1.95 May Not Compare To $1.30 Estimate, Sales $2.88B Miss $2.93B Estimate   Benzinga
04:03PM EDT  DaVita Q2 EPS $1.62 Vs. $1.64 Year Ago   RTTNews
04:02PM EDT  DaVita Inc. 2nd Quarter 2020 Results   PR Newswire
04:06AM EDT  Earnings Scheduled For July 30, 2020   Benzinga
Jul 15, 2020
04:01PM EDT  DaVita Inc. Schedules 2nd Quarter 2020 Investor Conference Call   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC